Optiver Holding
INBX icon

Optiver Holding’s Inhibrx INBX Stock Holding History

Optiver Holding’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.6K Sell
576
-386
-40% -$38.7K ﹤0.01% 1138
2026
Q1 		$64.7K Buy
962
+30
+3% +$2.23K ﹤0.01% 925
2025
Q4 		$73.6K Buy
932
+818
+718% +$55.7K ﹤0.01% 855
2025
Q3 		$3.84K Buy
+114
New +$2.81K ﹤0.01% 1986

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Optiver Holding's INBX Position: Q2 2026 in Review

Optiver Holding reduced its Inhibrx (INBX) stake by 40% in Q2 2026, selling an estimated $38.7K and leaving 576 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

Optiver Holding first reported a position in INBX in Q3 2025 and has held it in 4 quarters since. The position peaked at $73.6K in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Optiver Holding held 576 shares of Inhibrx worth $54.6K as of Q2 2026.
  • Optiver Holding sold 386 Inhibrx shares in Q2 2026, an estimated $38.7K.
  • Inhibrx made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1138 holding.
  • Optiver Holding first reported a position in Inhibrx in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Inhibrx position peaked at $73.6K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.